Storage, expansion and future therapeutic applications of tissues and stem cells

Not�cias Cryo-Save Group

Data	Titulo	Resumo
27/11/2008	Start of sample storage in India	Cryo-Save India Private Limited, a wholly owned subsidiary of Cryo-Save, has instituted its state-of-the-art facility and R&D centre, slated to service India as well as the South-East Asia area in the near future, in Bangalore.
22/07/2008	Acquisition of leading Balkan distributor	Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save", or "the Group"), Europe's leading adult stem cell storage bank, has acquired Cryo-Save Balcanica S.A. ("Cryo-Save Balcanica") of Athens, for an initial consideration of �4.1 million payable in cash.
08/07/2008	Acquisition of leading Spanish distributor	Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's leading adult stem cell storage bank, has acquired its Spanish distributor, Crio Cord, S.L. ("Crio Cord") for an initial consideration of �16 million payable in cash.
04/06/2008	Launch of CryoCord	CryoCord launched as storage of mesenchymal stem cells from umbilical cord tissue starts.
13/03/2008	Launch in India	Cryo-Save Group N.V. (AIM: CRYO, �Cryo-Save� or �the Group�), Europe�s largest adult stem cell storage bank, has established an Indian operation, Cryo-Save India Private Ltd ("Cryo-Save India"), will build a new storage laboratory in Belgium and has acquired its South African distributor CRYOCLINIC (Pty) Ltd ("Cryoclinic").
31/01/2008	Acquisition of Hungarian distributor	Cryo-Save Group N.V. (AIM: CRYO, "Cryo-Save" or "the Group"), Europe's largest adult stem cell storage bank, announces that it has acquired its Hungarian distributor, Sejtbank.
16/07/2007	Crian�a portuguesa tratada com sucesso com c�lulas estaminais armazenadas em banco privado	Porto / Bruxelas, 16 de Julho 2007. � Uma crian�a diagnosticada com um s�ndrome de defici�ncia imunol�gica grave de c�lulas T (CD8+) foi tratada com sucesso recorrendo a c�lulas estaminais do cord�o umbilical, em Portugal. A defici�ncia cong�nita foi diagnosticada em Coimbra. O tratamento de transplanta��o foi efectuado na Unidade de Transplanta��o de medula �ssea (director: Dr. Pedro Pimentel) do Instituto Portugu�s de Oncologia do Porto (IPO Porto). A Dra. Alzira Carvalhais � a Chefe do Departamento de Imunohemoterapia.